// App-Quantinova.ai

2445 : Next-Generation STAT3 Inhibitors As Targeted Therapeutics in Chronic Myeloid Leukemia.

Researchers

Presenter

  • Anna M. Eiring

Principal Investigators

  • Brent DG Page

  • Patrick T Gunning

  • Thomas -Hare

  • Michael W Deininger

  • Clinton C Mason

  • Zhimin Gu

  • Jamshid S Khorashad

  • David J Anderson

  • Anthony D Pomicter

  • Kimberly R Reynolds

  • Johanna Estrada

  • Matthew S Zabriskie

Medical Centers

  • Department of Chemistry, University of Toronto Mississauga, Mississauga, ON, Canada

  • Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 34

  • Signal transducer and activator of transcription 3

Drug/Treatment

  • Imatinib

  • IkT001

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved